Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Clin Cancer Res. 2019 Apr 23;25(14):4332–4342. doi: 10.1158/1078-0432.CCR-18-3312

Figure 1. Structure and components of the SSTR2-targeted intraoperative imaging agent.

Figure 1.

MMC-mediated radiolabeling enables quantitative characterization of the fluorescent somatostatin analog, MMC(IR800)-TOC.